Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Other Non-Current Assets (2016 - 2025)

Fortress Biotech has reported Other Non-Current Assets over the past 13 years, most recently at $401000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $401000.0 for Q4 2025, down 45.14% from a year ago — trailing twelve months through Dec 2025 was $401000.0 (down 45.14% YoY), and the annual figure for FY2025 was $401000.0, down 45.14%.
  • Other Non-Current Assets for Q4 2025 was $401000.0 at Fortress Biotech, down from $18.1 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for FBIO hit a ceiling of $18.1 million in Q3 2025 and a floor of $401000.0 in Q4 2025.
  • Median Other Non-Current Assets over the past 5 years was $2.1 million (2021), compared with a mean of $2.7 million.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 93.24% in 2021 and later skyrocketed 440.57% in 2025.
  • Fortress Biotech's Other Non-Current Assets stood at $2.2 million in 2021, then increased by 21.08% to $2.7 million in 2022, then decreased by 9.3% to $2.4 million in 2023, then crashed by 70.02% to $731000.0 in 2024, then plummeted by 45.14% to $401000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $401000.0 (Q4 2025), $18.1 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.